Article info

Download PDFPDF
Cost benefit analysis of amethocaine (Ametop) compared with EMLA for intravenous cannulation in a children's emergency department
  1. Correspondence to Dr David Herd, Children's Emergency Department, Starship Children's Hospital, Park Road, Auckland 1023, New Zealand; david.herd{at}mac.com
View Full Text

Citation

Herd DW, Newbury C, Brown PM
Cost benefit analysis of amethocaine (Ametop) compared with EMLA for intravenous cannulation in a children's emergency department

Publication history

  • Accepted July 14, 2009
  • First published June 18, 2010.
Online issue publication 
June 18, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.